SCHEMBL5167134

SCHEMBL5167134

CC(=O)OCOP(=O)(O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TPI1 P60174 1/20 0.38
PGD P52209 4/20 0.37
LPAR3 Q9UBY5 3/20 0.37
LPAR1 Q92633 2/20 0.37
LPAR2 Q9HBW0 2/20 0.37
PGK1 P00558 1/20 0.37
PGK2 P07205 1/20 0.37
GLA P06280 1/20 0.36
CHRM5 P08912 2/20 0.34
CHRM1 P11229 2/20 0.34
CHRM3 P20309 2/20 0.34
PGR P06401 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
HTR1A P08908 1/20 0.34
CHRNB2 P17787 1/20 0.34
TBXA2R P21731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10378936 0.85 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10GLACHRM5
SCHEMBL14019302 0.83 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10GLACHRM5
SCHEMBL7620877 0.82 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10GLACHRM5
SCHEMBL23286473 0.80 TPI1 (0.33) ALDH1A1LMNAHSD17B10TPI1PGD
SCHEMBL13301617 0.80 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10GLACHRM5
SCHEMBL16075571 0.79 PLA2G2A (0.37) ALDH1A1LMNAHSD17B10GLACHRM5
SCHEMBL1068126 0.79 TPI1 (0.41) ALDH1A1TPI1PGDLPAR3LPAR1
SCHEMBL5329190 0.78 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10LPAR3LPAR1
SCHEMBL14414241 0.78 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10LPAR3LPAR1
SCHEMBL5665027 0.78 LPAR3 (0.40) ALDH1A1TPI1LPAR3LPAR1LPAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105658787-A Neuronal stem cell differentiation 加的夫大学学院咨询有限公司 2016-06-08 CN claimed
WO-2007149554-A2 METHODS FOR RESTORING NEURAL FUNCTION THE JOHNS HOPKINS UNIVERSITY (US) 2007-12-27 WO claimed
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
WO-2017184871-A1 CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USE ABBVIE INC. (US) 2017-10-26 WO disclosed
US-20170283446-A1 SOLUBLE C5aR ANTAGONISTS CHEMOCENTRYX, INC. 2017-10-05 US disclosed
US-20160264567-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GENENTECH, INC. (US) 2016-09-15 US disclosed
CN-105658787-A Neuronal stem cell differentiation 加的夫大学学院咨询有限公司 2016-06-08 CN disclosed
US-20160139136-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION (US) 2016-05-19 US disclosed
US-20160139136-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION (US) 2016-05-19 US disclosed
CN-104220053-A Modulators of exchange proteins directly activated by camp (epacs) UNIV TEXAS 2014-12-17 CN disclosed
WO-2007149554-A2 METHODS FOR RESTORING NEURAL FUNCTION THE JOHNS HOPKINS UNIVERSITY (US) 2007-12-27 WO disclosed
US-5834436-A CYCLOHEXANES SUBSTITUTED BY ACYLOXYALKYL PHOSPHATE ESTERS AS CARRIERS WHICH CAN PENETRATE CELL MEMBRANES WITHOUT DISRUPTING IT; THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-11-10 US disclosed
WO-1998026786-A1 CAGED MEMBRANE-PERMEANT INOSITOL PHOSPHATES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-06-25 WO disclosed
EP-0842181-A1 MEMBRANE-PERMEANT SECOND MESSENGERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-05-20 EP disclosed
US-5693521-A USING ACETOXYALKYL ESTER OF ADENOSINE(OR GUANOSINE)-3',5'-CYCLIC MONNOPHOSPHATE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-12-02 US disclosed
WO-1996040695-A1 MEMBRANE-PERMEANT SECOND MESSENGERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-12-19 WO disclosed
WO-1994023724-A1 MEMBRANE-PERMEANT SECOND MESSENGERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-10-27 WO disclosed
US-4968788-A DRUG DELIVERY, ANTITUMOR AGENTS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1990-11-06 US disclosed
WO-1990008155-A1 BIOLOGICALLY REVERSIBLE PHOSPHATE AND PHOSPHONATE PROTECTIVE GROUPS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1990-07-26 WO disclosed
US-4816570-A Biologically reversible phosphate and phosphonate protective groups THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 1989-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170283446-A1 SOLUBLE C5aR ANTAGONISTS C5AR1, C3AR1, C5AR2 ALDH1A1 2187/4885LMNA 3699/4885HSD17B10 4114/4885
US-20160139136-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS FUT5, FUT6, CSGALNACT1 ALDH1A1 4000/4885LMNA 1566/4885HSD17B10 4618/4885
US-20160264567-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS TRPA1, TRPV1, TRPV5 ALDH1A1 461/4885LMNA 2609/4885HSD17B10 2586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.